The week in cannabis has been an eventful one – on a global level. Below is a recap of news that the Green Flower team is following.
World Health Organization recommends rescheduling cannabis
What happened: The World Health Organization recommended this week that cannabis be rescheduled at the international level.
Cannabis is currently scheduled as a Schedule IV substance at the international level – the most restrictive level (not to be confused with Schedule I in the United States).
Why it matters: The recommendation by the World Health Organization is a really, really big deal. If the recommendation is followed, it would pave the way for an explosion of cannabis reform worldwide.
Harvard finds shocking new information about cannabis and sperm
What happened: A study conducted at Harvard examined the sperm of more than 660 men and asked them if they consumed cannabis or not.
The study found that male cannabis users had a higher sperm concentration than males that did not use cannabis.
Why it matters: Researchers expected the opposite to be true, which is likely because of how much stigma and false information has been spread about this topic.
Yet another talking point for cannabis opponents has gone up in smoke (no pun intended).
Potential U.S. Attorney General reiterates a hands-off approach to cannabis policy
What happened: William Barr was nominated by president Trump for U.S. Attorney General and is under Senate confirmation consideration.
This week he reiterated his desire to have a hands-off approach to state-level cannabis policy in a meeting with Republican Colorado Senator Cory Gardner.
Why it matters: It wasn’t that long ago that passionate cannabis opponent Jeff Sessions was U.S. Attorney General.
If Barr gets confirmed, and if he keeps his word, it would be good news for the cannabis industry and consumers in legal states.
House subcommittee to hold a hearing on cannabis banking legislation
What happened: The House Consumer Protection and Financial Institutions Subcommittee will hold a hearing next week on cannabis industry banking access.
The hearing is going to be held at 2 p.m. on February 13.
Why it matters: Banking access has been an issue for the cannabis industry for many years now.
The situation has improved with more financial institutions being open to working with cannabis businesses, and comprehensive reform is still desperately needed.
Florida judge rules that medical cannabis dispensary cap is unconstitutional
What happened: Florida Second Circuit Court Judge Karen Gievers ruled this week that a cap on medical cannabis licenses in the state is unconstitutional.
It is unclear at this time as to how the state of Florida will change its approach to licensing.
Why it matters: Florida’s medical cannabis program has over 176,000 patients, and that number is increasing with every update.
Florida’s medical cannabis patients deserve to have safe access, and hopefully this court ruling helps suffering patients get more access in their area to the medicine that they need.
CBD is ordered off of shelves and from restaurants
What happened: State health officials in Maine have ordered that products containing CBD be pulled from store shelves.
New York Department of Health and Mental Hygiene also ordered restaurants within its jurisdiction to refrain from using CBD in food.
Why it matters: The confusion over hemp policy continues. Many consumers assume that CBD is legal at all times, everywhere, but clearly that is not the case.
Fortunately, after the passage of the 2018 Farm Bill CBD moved one step closer towards full acceptance nationwide, and it will still be a bit before CBD has been put through the bureaucratic process.
– This article was originally posted at Green Flower
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CBDW? Ask our Editor
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
[email protected]
This article contains Third-Party Content submitted by third parties, including articles submitted through the CBDW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of CBDW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and CBDW does not endorse, guarantee or make representations concerning the accuracy and completeness of all third-party content. You acknowledge that by CBDW providing you with this internet portal that makes accessible to you the ability to view third-party content through the CBDW site, CBDW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. CBDW expressly disclaims liability relating to such third-party content. CBDW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, CBDW reserves the right to remove third-party content at any time in its sole discretion.
